IFNG and neoplasm: Treatment with the NO-donor NCX-4016 or PNT resulted in the inhibition of CAR T cell expansion (Fig. 4G and H) and diminished ability of CAR T cells to kill tumor cells (Fig. 4I) and secrete effector cytokines IFN-g and TNF-a (Extended Data Fig. 3K and L).